Reference : Does the metabolic syndrome help to select patients requiring high statin dose?

	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Pharmacy, pharmacology & toxicology Human health sciences : Endocrinology, metabolism & nutrition
	To cite this reference:	http://hdl.handle.net/2268/12080

Title :	Does the metabolic syndrome help to select patients requiring high statin dose?
Language :	English
Author, co-author :	Scheen, André [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Publication date :	2006
Journal title :	Lancet
Volume :	368
Issue/season :	9539
Pages :	893-4
Peer reviewed :	Yes (verified by ORBi)
e-ISSN :	1474-547X
Country :	England
Keywords :	[en] Anticholesteremic Agents/administration & dosage/therapeutic use ; Cardiovascular Diseases/etiology/prevention & control ; Coronary Disease/complications/drug therapy ; Diabetes Complications ; Dose-Response Relationship, Drug ; Heptanoic Acids/administration & dosage/therapeutic use ; Humans ; Incidence ; Metabolic Syndrome X/complications ; Patient Selection ; Pyrroles/administration & dosage/therapeutic use ; Risk Assessment ; Risk Factors
Permalink :	http://hdl.handle.net/2268/12080
DOI :	10.1016/S0140-6736(06)69293-3
Other URL :	http://www.thelancet.com

	File(s) associated to this reference
	Fulltext file(s): File Commentary Version Size Access Open access Does the metabolic syndrome help to select patients ocr.pdf Author postprint 108.57 kB View/Open

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5